Publications by authors named "Catherine Angwin"

Claim this Profile
A
Analysis of IgG responses to Sarcocystis neurona in horses with equine protozoal myeloencephalitis (EPM) suggests a Th1-biased immune response.
Catherine J Angwin, Izabela de Assis Rocha, Stephen M Reed, Jennifer K Morrow, Amy Graves

Vet Immunol Immunopathol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient stratification for determining optimal second-line and third-line therapy for type 2 diabetes: the TriMaster study.
Beverley M Shields, John M Dennis, Catherine D Angwin, Fiona Warren, William E Henley

Nat Med· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient preference for second- and third-line therapies in type 2 diabetes: a prespecified secondary endpoint of the TriMaster study.
Beverley M Shields, Catherine D Angwin, Maggie H Shepherd, Nicky Britten, Angus G Jones

Nat Med· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TriMaster: randomised double-blind crossover study of a DPP4 inhibitor, SGLT2 inhibitor and thiazolidinedione as second-line or third-line therapy in patients with type 2 diabetes who have suboptimal glycaemic control on metformin treatment with or without a sulfonylurea-a MASTERMIND study protocol.
Catherine Angwin, Caroline Jenkinson, Angus Jones, Christopher Jennison, William Henley

BMJ Open· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis